scorecardresearch
Add as a preferred source on Google
Tuesday, March 31, 2026
TopicNovartis

Topic: Novartis

India approves Zolgensma, one of world’s costliest drugs. Why it’s sparked hope, but also concern

Zolgensma is the only drug that promises a cure for Spinal Muscular Atrophy, provided it is administered to affected children before the symptoms appear.

In Delhi hospitals, thalassemia patients suffer as life-saving Desferal scarce, set to become 50% costlier

Doctors & patients confirm acute shortage of the drug in hospitals, even as manufacturer Novartis maintains there is no shortage in supply.

2 jabs a year to keep bad cholesterol at bay — breakthrough treatment to launch in India this month

Novartis India, the company that has the import and marketing permission for Inclisiran, refused to divulge the price of the drug in India, but market sources say it is going to be Rs 1.2 lakh per jab.

Novartis, Eli Lilly oppose compulsory licences for breast cancer drugs, say sales up despite price

Pharma giants were responding to petition in Kerala HC seeking compulsory licences for their HER2-negative breast cancer drugs, which would allow cheaper, generic versions to be made.

It’ll take more than vaccines to fight Covid, Novartis CEO Narasimhan says

Significant supplies of highly effective vaccines won’t be available until the end of 2021 & even once we have one, it probably won’t protect everyone, Narasimhan said.

On Camera

How West Asia crisis can play out for PM Modi and BJP in Assembly polls

While the Russia-Ukraine war saw the BJP projecting PM Modi as a ‘vishwaguru’ who could end international conflicts, the party has made a nuanced shift in its electoral strategy vis-à-vis the West Asia war.

Foreign investors dump record $12 bn India stocks in March on war

Soaring energy costs have hurt oil-importing Asian peers, but the scale of outflows from India points to already bearish global sentiment.

India developing lethal autonomous weapon systems, database of citizens’ crime risk—House Panel report

Report on impact of AI emergence—drawing upon depositions from several ministries—confirms that the developments come in the absence of AI laws or considerations over them.

Gulf war exposed India’s fragilities. It’s time for navel-gazing, in the national interest

It’s easy to understand why the government can’t speak the hard truth. When this war ends, as all wars do, India’s interests will lie with both the winner and the loser.